Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewElena Erroba, winner of the Navarra 2021 Management Award organised by AMEDNA-NEEZE
Along with Elena, Maite Agüeros Bazo was awarded as Businesswoman of Navarre 2021 and Susana Sánchez as Entrepreneur of Navarre 2021.
-
-
NewORYZON enrolls first patient in EVOLUTION, a Phase IIb clinical trial with vafidemstat in ...
Primary objectives: to assess the effect of vafidemstat to address negative and cognitive symptoms in schizophrenia Phase IIb adaptive trial planning to enroll 100 patients Second Phase IIb study of
-
NewBiotechnology in PERTE for “Vanguard Health”
Rocío Arroyo, CEO of Amadix and coordinator of the AseBio Personalised Medicine Workgroup, highlighted the role biotechnology companies play throughout the R&D cycle
-
NewORYZON publishes paper in ACS Pharmacology & Translational Science supporting best-in-cla...
Iadademstat consistently stronger in viability reduction in AML & SCLC cells Superior target engagement at low concentration in AML & SCLC cells Superior disruption of the Snag-domain protein-protein
-
Press releaseBiofuel, bioplastics and crops resistant to extreme weather, among the most noteworthy cli...
This Thursday is the next-to-last day of COP26 and the association believes it is important to remember that biotechnology can cut greenhouse-gas emissions up to 65% and has a direct impact on 11 of
-
NewBiofuel, bioplastics and crops resistant to extreme weather, among the most noteworthy cli...
This Thursday is the next-to-last day of COP26 and the association believes it is important to remember that biotechnology can cut greenhouse-gas emissions up to 65% and has a direct impact on 11 of
-
-
NewIUL presents IPEAK® EUROPIUM, a new lateral flow reader for fluorescence labeled lateral ...
IUL presents a new fluorescence lateral flow reader in the framework of the Advanced Lateral Flow Conference in San Diego 2021. iPeak® Europium represents a fundamental advance in the lateral flow
-
NewBCN HEALTH publishes a study evaluating the incidence and medical costs associated to pneu...
BCN HEALTH conducted a retrospective study based on the records of patients hospitalized due to pneumococcal disease and treated in Spanish public and private hospitals between January of 2008 and
-
NewYsios Capital’s portfolio company Aura Biosciences prices IPO on NASDAQ
Aura Biosciences, Inc. is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates (VDCs) to target and destroy cancer cells selectively while
-
NewMore than 1,750 students participate in the 2nd edition launch of “Reimagine Science”
More than 1,750 young high school students from all over Catalonia participate in the launch of the second edition of “Reimagine Science: clinical trials, research and drug development” programme by
-
EventBiotech Showcase Digital 2022
The event will be delivered digitally January 10–12, 2022 and January 17–19, 2022 on partneringONE®.
-
NewCommercial Adoption of Herdscreen® ASFV Antibody Test in Europe
New pen-side test allows for highly specific, sensitive detection of infected animals or contaminated pig-derived products
-
NewArchivel Farma is proud to announce the recruitment of the first patient in the STriTuVaD ...
The clinical trials will be conducted in two centers in India: the All India Institute Of Medical Sciences (AIIMS) of New Delhi, and the Agartala Government Medical College of Agartala
-
NewAsphalion launches CTIS support and training programme
CTIS will be the single entry point for submitting clinical trial information in the EU
-
NewBCN HEALTH presents three communications in the congress ISPOR Europe based on retrospecti...
The objectives of the study were to describe patient characteristics, calculate hospital incidence and mortality associated with Alzheimer's disease in Spain, and assess direct medical costs at
-
NewA study we co-authored out today in JAMA Pediatrics supports the widespread adoption and i...
Study population mirrors diversity of US demographics and findings demonstrate that whole genome sequencing should be considered a first-line test for patients with suspected genetic disease
-
NewORYZON enrolls first patient in the US in PORTICO, a Phase IIb clinical trial with vafide...
PORTICO already recruiting in several European countries
-
EventWhy WE Lead Food?
-
CompanySANOFI